Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
C01AA05	LANOXIN	B	Digoxin - 0.25mg	0.25mg	Tablet	215,015 L.L
L01XK04	TALZENNA	B	Talazoparib - 0.25mg	0.25mg	Capsule	133,836,699 L.L
N05BA12	ALPRAZOLAM BIOGARAN	G	Alprazolam - 0.25mg	0.25mg	Tablet, scored	115,570 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
N02CX01	APIZINE	G	Pizotifen - 0.25mg/5ml	0.25mg/5ml	Syrup	505,541 L.L
A04AA05	ALOXI	B	Palonosetron HCl - 0.25mg/5ml	0.25mg/5ml	Injectable solution	3,656,595 L.L
D07AC04	FLUOCINOLONE ACETONIDE	G	Fluocinolone acetonide - 0.25mg/g	0.25mg/g	Cream	296,925 L.L
A03BA01	ATROPINE I.V. 0.25 MG.	G	Atropine - 0.25mg/ml	0.25mg/ml	Injectable solution	2,412,129 L.L
S01GX08	ZALERG	G	Ketotifen - 0.25mg/ml	0.25mg/ml	Drops solution	446,156 L.L
B01AC17	AGGRASTAT	B	Tirofiban hydrochloride monohydrate - 0.25mg/ml	0.25mg/ml	Injectable concentrated solution	18,280,324 L.L
A11CC06	HIDROFEROL	G	Calcifediol - 0.266mg	0.266mg	Capsule, soft	1,316,966 L.L
D10AX03	SKINOREN	B	Azelaic acid - 0.2g/g	0.2g/g	Cream	722,987 L.L
C02AC05	CYNT	B	Moxonidine - 0.2mg	0.2mg	Tablet, film coated	901,735 L.L
A03AB02	GLYCOPYRROLATE	B	Glycopyronium Bromide - 0.2mg/ml	0.2mg/ml	Injectable solution	7,238,185 L.L
D10AD03	DIFADERM	G	Adapalene - 0.3%	0.3%	Gel	952,208 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01AA12	TOBRASTILL	G	Tobramycin - 0.3%	0.3%	Drops solution	258,018 L.L
S01AA12	TOBRIN	G	Tobramycin - 0.3%	0.3%	Drops	169,324 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Ointment	280,863 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Drops solution	681,328 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Ointment	593,978 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
R06AD08	TOPLEXIL	B	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	615,480 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.375mg	0.375mg	Tablet, extended release	473,033 L.L
N02BA01	ASPIRINE	B	Acetylsalicylic acid - 300mg	0.3g	Tablet	80,631 L.L
C02AC05	CYNT	B	Moxonidine - 0.3mg	0.3mg	Tablet, film coated	1,218,134 L.L